Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages. [electronic resource]
Producer: 20040625Description: 283-92 p. digitalISSN:- 1044-5498
- Acetamides
- Acetates -- pharmacology
- Anilides -- pharmacology
- Cardiovascular Agents -- pharmacology
- Cell Line
- Enzyme Inhibitors -- pharmacology
- Fatty Acids, Monounsaturated -- pharmacology
- Fenofibrate -- analogs & derivatives
- Fluvastatin
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Indoles -- pharmacology
- Lipoproteins, LDL -- pharmacology
- Macrophages -- cytology
- Matrix Metalloproteinase 9 -- genetics
- Matrix Metalloproteinase Inhibitors
- Mevalonic Acid -- pharmacology
- Monocytes -- drug effects
- Pyrimidines -- pharmacology
- Receptors, Cytoplasmic and Nuclear -- agonists
- Rosiglitazone
- Sterol O-Acyltransferase -- antagonists & inhibitors
- Sulfonamides
- Sulfonic Acids -- pharmacology
- Tetradecanoylphorbol Acetate -- pharmacology
- Thiazolidinediones -- pharmacology
- Tissue Inhibitor of Metalloproteinase-1 -- drug effects
- Transcription Factors -- agonists
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.